Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Laird

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nucleic Acids Research|March 29, 2000
MethyLight: a high-throughput assay to measure DNA methylationC A Eads, K D Danenberg, K Kawakami, et al.
Cell|April 21, 1995
Suppression of intestinal neoplasia by DNA hypomethylationP W Laird, L Jackson-Grusby, A Fazeli, et al.
Blood|September 1, 1993
Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cellsJ Domen, N M van der Lugt, P W Laird, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Mouse model systems to study multistep tumorigenesisA Berns, N van der Lugt, M Alkema, et al.
Gut|January 13, 2006
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studiesS Ogino, M Cantor, T Kawasaki, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2003
Phase I trial of continuous infusion 5-aza-2'-deoxycytidineA Aparicio, C A Eads, L A Leong, et al.
Oncogene|March 15, 2006
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumorsM Ehrlich, C B Woods, M C Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomasZ Xiong, A H Wu, C M Bender, et al.
Cancer Research|April 20, 2001
Epigenetic patterns in the progression of esophageal adenocarcinomaC A Eads, R V Lord, K Wickramasinghe, et al.
Cancer Research|October 4, 2000
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinomaC A Eads, R V Lord, S K Kurumboor, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nucleic Acids Research|March 29, 2000
MethyLight: a high-throughput assay to measure DNA methylationC A Eads, K D Danenberg, K Kawakami, et al.
Cell|April 21, 1995
Suppression of intestinal neoplasia by DNA hypomethylationP W Laird, L Jackson-Grusby, A Fazeli, et al.
Blood|September 1, 1993
Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cellsJ Domen, N M van der Lugt, P W Laird, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Mouse model systems to study multistep tumorigenesisA Berns, N van der Lugt, M Alkema, et al.
Gut|January 13, 2006
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studiesS Ogino, M Cantor, T Kawasaki, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2003
Phase I trial of continuous infusion 5-aza-2'-deoxycytidineA Aparicio, C A Eads, L A Leong, et al.
Oncogene|March 15, 2006
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumorsM Ehrlich, C B Woods, M C Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomasZ Xiong, A H Wu, C M Bender, et al.
Cancer Research|April 20, 2001
Epigenetic patterns in the progression of esophageal adenocarcinomaC A Eads, R V Lord, K Wickramasinghe, et al.
Cancer Research|October 4, 2000
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinomaC A Eads, R V Lord, S K Kurumboor, et al.
Pageof 5